ARCHIVES

New Safety Concerns On ESAs Prompt FDA To Consult ODAC Again.

This article is from The Cancer Letter archive.

Vol. 34 No. 01 | January 11, 2008

Download PDF Visit The Full Archive

Related Articles

Genentech’s Ferrara Selected for GM Award.

June 23, 2006

NCI Study Says 2 Million US Women Could Benefit from Tamoxifen

April 11, 2003

RFP: Sole Source

May 12, 2000

The NLST at a Glance

August 2, 2013

In Brief: Schweitzer ACS President, Dodd President Elect, FDA Commissioner Resigns Abruptly

November 17, 1989

Mihich Subcommittee Recommendations For Augmenting Agents In BRMP Described

December 7, 1979